{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:03:38Z","timestamp":1790233418609,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejrad.2026.113192","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:38:56Z","timestamp":1787701136000},"page":"113192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In an era of changing contrast agents, is there still a role for premedication in specific clinical scenarios to reduce recurrent hypersensitivity reactions after intravascular contrast agent administration?"],"prefix":"10.1016","volume":"204","author":[{"given":"Aart J.","family":"van der Molen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-0714","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.113192_b0005","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.282.6268.974","article-title":"Clinical pharmacology: adverse reactions to drugs","volume":"282","author":"Rawlins","year":"1981","journal-title":"BMJ"},{"key":"10.1016\/j.ejrad.2026.113192_b0010","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1007\/s00330-025-11675-1","article-title":"Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee","volume":"35","author":"van der Molen","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0015","first-page":"51","article-title":"Immediate hypersensitivity to contrast agents: the French 5-year CIRTACI study, E","volume":"1","author":"Cl\u00e9ment","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejrad.2026.113192_b0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.18176\/jiaci.0341","article-title":"Hypothesized epitope localization in hypersensitivity reactions to iodinated contrast media","volume":"29","author":"Borras","year":"2019","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2026.112996","article-title":"Hypersensitivity reactions after intravascular administration of nonionic iodine-based contrast media: evidence on the influence of different sidechains on cross-reactivity","volume":"203","author":"van der Molen","year":"2026","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00016925109136647","article-title":"Antihistaminic drugs for inhibiting untoward reactions to injections of contrast medium","volume":"35","author":"Olsson","year":"1951","journal-title":"Acta Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0022-5347(17)68599-9","article-title":"Use of antihistamine drug prophylaxis against diodrast reactions","volume":"65","author":"Getzoff","year":"1951","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2026.113192_b0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7326\/0003-4819-83-2-159","article-title":"An approach to the performance of contrast studies in contrast material-reactive persons","volume":"83","author":"Zweiman","year":"1975","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejrad.2026.113192_b0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0091-6749(75)90007-X","article-title":"The administration of radiographic contrast media to patients with a history of a previous reaction","volume":"55","author":"Schatz","year":"1975","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0091-6749(78)90104-5","article-title":"Radiographic contrast media studies in high-risk patients","volume":"62","author":"Kelly","year":"1978","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0055","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.1985.00360120065011","article-title":"Prophylaxis against repeated radiocontrast media reactions in 857 cases. adverse experience with cimetidine and safety of beta-adrenergic antagonists","volume":"145","author":"Greenberger","year":"1985","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejrad.2026.113192_b0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM198710013171401","article-title":"Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material","volume":"317","author":"Lasser","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2026.113192_b0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2214\/ajr.150.2.257","article-title":"Pretreatment with corticosteroids to prevent reactions to i.v. contrast material: overview and implications","volume":"150","author":"Lasser","year":"1988","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113192_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2342-6-2","article-title":"The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review","volume":"6","author":"Delaney","year":"2006","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.ejrad.2026.113192_b0075","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.38981.652118.DE","article-title":"Adverse reactions to intravascular contrast agents","volume":"333","author":"Dawson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ejrad.2026.113192_b0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bmj.38905.634132.AE","article-title":"Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review","volume":"333","author":"Tram\u00e8r","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ejrad.2026.113192_b0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.rcl.2016.10.012","article-title":"The evidence for and against corticosteroid prophylaxis in at-risk patients","volume":"55","author":"Davenport","year":"2017","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.ejrad.2026.113192_b0090","unstructured":"American College of Radiology. ACR Manual on Contrast Media. v2025. Available at: https:\/\/www.acr.org\/Clinical-Resources\/Contrast-Manual. Accessed: 30 June 2026."},{"issue":"6 Suppl","key":"10.1016\/j.ejrad.2026.113192_b0095","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/00004424-198011001-00010","article-title":"The current status of reactions to intravenous contrast media","volume":"15","author":"Ansell","year":"1980","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13244-025-02099-y","article-title":"Risk factor analysis of iodinated contrast medium-related hypersensitivity reactions","volume":"16","author":"Beiner","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejrad.2026.113192_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.2019190485","article-title":"Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients","volume":"293","author":"Cha","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112472","article-title":"Risk factors associated with immediate hypersensitivity reaction to contrast media: a systematic review and meta-analysis","volume":"194","author":"Huang","year":"2026","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0115","first-page":"9","article-title":"Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial","volume":"78","author":"Ring","year":"1985","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0120","first-page":"169","article-title":"Premedication with H1- and H2-receptor antagonists for intravenous urography using contrast media [in German]","volume":"144","author":"Reimann","year":"1986","journal-title":"R\u00f6fo"},{"key":"10.1016\/j.ejrad.2026.113192_b0125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(84)90391-9","article-title":"Two pretreatment regimens for high-risk patients receiving radiographic contrast media","volume":"74","author":"Greenberger","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0091-6749(86)90357-X","article-title":"Emergency administration of radiocontrast media in high-risk patients","volume":"77","author":"Greenberger","year":"1986","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0135","first-page":"70","article-title":"Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media","volume":"67","author":"Marshall","year":"1991","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.ejrad.2026.113192_b0140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00004424-199105000-00003","article-title":"Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents","volume":"126","author":"Wolf","year":"1991","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0145","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0091-6749(91)90135-B","article-title":"The prevention of immediate generalized reactions to radiocontrast media in high-risk patients","volume":"87","author":"Greenberger","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1148\/radiology.184.2.1620832","article-title":"Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media","volume":"184","author":"Bertrand","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2214\/ajr.162.3.8109489","article-title":"Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media","volume":"162","author":"Lasser","year":"1994","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113192_b0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0009-9260(05)83148-4","article-title":"Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents","volume":"150","author":"Lasser","year":"1995","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.2017170107","article-title":"Intravenous corticosteroid premedication administered 5 hours before CT compared with a traditional 13-hour oral regimen","volume":"285","author":"Mervak","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0170","doi-asserted-by":"crossref","unstructured":"D.A. Tonetti, S.M. Desai, A. Morrison, B.A. Gross, T.G. Jovin, B.T. Jankowitz BT, et al., Emergent premedication for contrast allergy prior to endovascular treatment of acute ischemic stroke, AJNR Am. J. Neuroradiol. 41 (2020) 1647-1651, doi: 10.3174\/ajnr.A6720.","DOI":"10.3174\/ajnr.A6720"},{"key":"10.1016\/j.ejrad.2026.113192_b0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008672","article-title":"Clinical efficacy of emergency premedication regimen for contrast allergy before percutaneous coronary interventions","volume":"13","author":"Jha","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ejrad.2026.113192_b0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0009-9260(05)81969-5","article-title":"Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents: a survey of current practice in the UK","volume":"49","author":"Seymour","year":"1994","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1148\/radiology.194.2.7824710","article-title":"Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology","volume":"194","author":"Cohan","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0190","doi-asserted-by":"crossref","unstructured":"S. Radhakrishnan, S .Manoharan, M. Fleet, Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents, Clin. Radiol. 60 (2005) 58-63; discussion 56-57, doi: 10.1016\/j.crad.2004.05.020.","DOI":"10.1016\/j.crad.2004.05.020"},{"key":"10.1016\/j.ejrad.2026.113192_b0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacr.2010.09.001","article-title":"A survey on the use of premedication prior to iodinated and gadolinium-based contrast material administration","volume":"8","author":"O'Malley","year":"2011","journal-title":"J. Am. Coll. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0200","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacr.2023.04.024","article-title":"A survey of practicing radiologists on the use of premedication before intravenous iodinated contrast medium administration","volume":"21","author":"Sodagari","year":"2024","journal-title":"J. Am. Coll. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0205","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2214\/ajr.176.6.1761389","article-title":"Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication","volume":"176","author":"Freed","year":"2001","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113192_b0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1148\/radiol.2532090465","article-title":"Repeat contrast medium reactions in premedicated patients: frequency and severity","volume":"253","author":"Davenport","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2214\/AJR.14.13810","article-title":"Rates of breakthrough reactions in inpatients at high risk receiving premedication before contrast-enhanced CT","volume":"205","author":"Mervak","year":"2015","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113192_b0220","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.21037\/qims-23-912","article-title":"Immediate hypersensitivity reactions to iodinated contrast media despite drug prophylaxis - a comparative retrospective cohort study of breakthrough reactions in Bern (Switzerland) and Seoul (South Korea)","volume":"14","author":"Beiner","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.ejrad.2026.113192_b0225","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/all.14656","article-title":"Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity","volume":"76","author":"Torres","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2026.113192_b0230","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1007\/s00330-025-11676-0","article-title":"Hypersensitivity reactions to contrast media. Part 2: Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee","volume":"35","author":"van der Molen","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0235","article-title":"Management and prevention of hypersensitivity reactions to radiocontrast media: a consensus statement from the American College of Radiology and the American Academy of Allergy","volume":"315","author":"Wang","year":"2025","journal-title":"Asthma & Immunology, Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/08465371241311253","article-title":"CAR\/CSACI practice guidance for contrast media hypersensitivity","volume":"76","author":"Byrne","year":"2025","journal-title":"Can. Assoc. Radiol. J."},{"key":"10.1016\/j.ejrad.2026.113192_b0245","doi-asserted-by":"crossref","unstructured":"A. Byrne, D.B. Macdonald, I.D.C. Kirkpatrick, M. Pham, A.M. Copaescu, M.D.F. McInnes, et al., CAR\/CSACI practice guidance for contrast media hypersensitivity: update for unknown contrast agents. Can Assoc Radiol J. 77 (2026) Online ahead of print, doi: 10.1177\/08465371251401551.","DOI":"10.1177\/08465371251401551"},{"key":"10.1016\/j.ejrad.2026.113192_b0250","first-page":"432","article-title":"Premedication of patients for prior urticarial reaction to iodinated contrast medium, Abdom","volume":"39","author":"Kolbe","year":"2014","journal-title":"Imaging"},{"key":"10.1016\/j.ejrad.2026.113192_b0255","first-page":"164","article-title":"The efficacy of single premedication with antihistamines for radiocontrast media hypersensitivity, Asia Pac","volume":"6","author":"Lee","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.ejrad.2026.113192_b0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.anai.2016.11.027","article-title":"Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients","volume":"118","author":"Lee","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0265","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1148\/radiol.2018172524","article-title":"Immediate mild reactions to CT with iodinated contrast media: strategy of contrast media readministration without corticosteroids","volume":"288","author":"Park","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109152","article-title":"Corticosteroid prophylaxis may not be required for patients with mild hypersensitivity reaction to low-osmolar contrast media","volume":"130","author":"Park","year":"2020","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0275","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1007\/s00330-016-4682-y","article-title":"Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: a multicentre retrospective cohort study","volume":"27","author":"Park","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anai.2016.07.010","article-title":"Outcomes of corticosteroid prophylaxis for hypersensitivity reactions to low osmolar contrast media in high-risk patients","volume":"117","author":"Jung","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejrad.2026.113192_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100561","article-title":"Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media","volume":"14","author":"Kim","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.ejrad.2026.113192_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110101","article-title":"Incidence and risk factors of late adverse reactions to low-osmolar contrast media: a prospective observational study of 10,540 exposures","volume":"146","author":"Kang","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0295","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1007\/s00330-015-4028-1","article-title":"Protective effect against repeat adverse reactions to iodinated contrast medium: premedication vs. changing the contrast medium","volume":"26","author":"Abe","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0300","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1148\/radiol.2021210490","article-title":"Prevention of allergic-like reactions at repeat CT: steroid pretreatment versus contrast material substitution","volume":"301","author":"McDonald","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0305","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222467","article-title":"Substitution with low-osmolar iodinated contrast agent to minimize recurrent immediate hypersensitivity reaction","volume":"309","author":"Kim","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0310","doi-asserted-by":"crossref","first-page":"W483","DOI":"10.2214\/AJR.09.3906","article-title":"Hyperglycemic consequences of corticosteroid premedication in an outpatient population","volume":"194","author":"Davenport","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113192_b0315","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.acra.2010.11.007","article-title":"Hyperglycemia in hospitalized patients receiving corticosteroid premedication before the administration of radiologic contrast medium","volume":"18","author":"Davenport","year":"2011","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0320","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1148\/radiol.2015151143","article-title":"Indirect cost and harm attributable to oral 13-hour inpatient corticosteroid prophylaxis before contrast-enhanced CT","volume":"279","author":"Davenport","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113192_b0325","first-page":"1392","article-title":"Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions","volume":"96","author":"Amr","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ejrad.2026.113192_b0330","doi-asserted-by":"crossref","unstructured":"[Letters to the editor], Corticosteroids and allergies to contrast material, N. Engl. J. Med. 318 (1988) 856-857, doi: 10.1056\/NEJM198803313181314.","DOI":"10.1056\/NEJM198803313181314"},{"key":"10.1016\/j.ejrad.2026.113192_b0335","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0009-9260(05)80300-9","article-title":"Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents?","volume":"48","author":"Dawson","year":"1993","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0340","doi-asserted-by":"crossref","unstructured":"E.C. Lasser, Corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents, Clin. Radiol. 49 (1994) 582-583; author reply 583-584.","DOI":"10.1016\/S0009-9260(05)82945-9"},{"key":"10.1016\/j.ejrad.2026.113192_b0345","doi-asserted-by":"crossref","unstructured":"Ansell G, Corticosteroid prophylaxis for contrast media reactions, Clin. Radiol. 49 (1994) 508; author reply 509-510, doi: 10.1016\/s0009-9260(05)81755-6.","DOI":"10.1016\/S0009-9260(05)81755-6"},{"key":"10.1016\/j.ejrad.2026.113192_b0350","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0009-9260(05)82946-0","article-title":"Letters to the Editor","volume":"49","author":"Dor\u00e9","year":"1994","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0355","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0009-9260(05)83060-0","article-title":"Corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents","volume":"50","author":"Dor\u00e9","year":"1995","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0360","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2214\/ajr.164.2.7840006","article-title":"Corticosteroid pretreatment and nonionic contrast media","volume":"164","author":"Seymour","year":"1995","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2026.113192_b0365","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1007\/s00330-024-10730-7","article-title":"N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions","volume":"34","author":"Kim","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0370","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00330-024-11114-7","article-title":"Substituting with alternative iodinated contrast medium to prevent recurrent adverse drug reactions associated with its use: a meta-analysis","volume":"35","author":"Lim","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0375","doi-asserted-by":"crossref","unstructured":"F. Vega, A.J. van der Molen, Adverse and hypersensitivity reactions after intravascular administration of nonionic iodine-based contrast media: do agent-specific differences inform contrast agent selection? Eur. Radiol. Abdomen 1 (2026) online ahead of publication, doi: 10.1007\/s44501-026-00012-6.","DOI":"10.1016\/j.ejrad.2026.112996"},{"key":"10.1016\/j.ejrad.2026.113192_b0380","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13244-024-01658-z","article-title":"How young radiologists use contrast media and manage adverse reactions: an international survey","volume":"15","author":"Albano","year":"2024","journal-title":"Insights. Imaging."},{"key":"10.1016\/j.ejrad.2026.113192_b0385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radi.2023.10.007","article-title":"Radiographers' confidence in handling iodine based contrast media hypersensitivity reactions","volume":"30","author":"Trygg","year":"2024","journal-title":"Radiography (lond)."},{"key":"10.1016\/j.ejrad.2026.113192_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112539","article-title":"Documentation of contrast hypersensitivity reactions: a socio-ecological scoping review","volume":"194","author":"Singh","year":"2026","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.113192_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112114","article-title":"RadioComics - always these problems with the documentation of contrast agent-induced hypersensitivity reactions","volume":"187","author":"B\u00f6hm","year":"2025","journal-title":"Eur. J. Radiol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:45:43Z","timestamp":1790232343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26005401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":79,"alternative-id":["S0720048X26005401"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113192","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In an era of changing contrast agents, is there still a role for premedication in specific clinical scenarios to reduce recurrent hypersensitivity reactions after intravascular contrast agent administration?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113192"}}